Back

Evidence for antithrombotic therapy from trials.

19 June 2017 (11:18 - 11:36)
Organised by:
Congress Presentation Part of: Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis Atrial fibrillation (AF) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)

4 More presentations in this session

Presentation thumbnail
Epidemiology of valvular atrial fibrillation and implications for stroke/thromboembolism.
Professor G. Boriani (Modena, IT)
Presentation thumbnail
Evidence for antithrombotic therapy from observational cohorts.
Professor L. Fauchier (Tours, FR)
Slides Video
Presentation thumbnail
Mechanical heart valves, bioprostheses, TAVI.
Professor J. Morais (Leiria, PT)
Slides Video
Presentation thumbnail
What the consensus document says.
Professor G. Lip (Liverpool, GB)

Access the full session

Session thumbnail
Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

19 June 2017 11:18 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources